News
CVS Caremark will stop covering Eli Lilly’s Zepbound. Wegovy, the GLP-1 medication to treat obesity from Lilly competitor ...
Employers, some lawmakers and others have criticized pharmacy benefit managers (PBMs), especially the "big three," for having ...
CVS adds Wegovy to its top formularies and bolsters its Weight Management program, aiming to expand access while cutting costs.
Patrick Conway, who recently became chief executive of the larger Optum health services division, will replace Dr. Amar Desai ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results